Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the efficacy and safety of AD-209
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Chang Gyu Park, M.D., Ph.D
CONTACT
Lead Sponsor
Addpharma Inc.
NCT05546931 · Hypertension,Essential, Adherence, Medication, and more
NCT05067998 · Anxiety Disorders and Symptoms, Fibromyalgia, and more
NCT04625569 · Hypertension,Essential, Salt; Excess, and more
NCT05972785 · Hypertension,Essential, Breast Cancer
NCT06501586 · Hypertension,Essential
Korea University Guro Hospital
Seoul
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions